Simplified approach to investigation of suspected VTE

Size: px
Start display at page:

Download "Simplified approach to investigation of suspected VTE"

Transcription

1 Simplified approach to investigation of suspected VTE Diagnosis of DVT and PE THSNA 2016, Chicago 15 April 2016 Clive Kearon, McMaster University, Canada

2 Relevant Disclosures Research Support/P.I. Employee Consultant Major Stockholder Speakers Bureau Honoraria Scientific Advisory Board Canadian Institutes Health Research Heart & Stroke Foundation of Ontario National Institutes of Health Bayer Inc. No relevant Bayer Inc. No relevant No relevant No relevant No relevant

3 Outline Goals of diagnostic testing Ruling-in & Rule-out VTE Clinical evaluation as a diagnostic test D-dimer (with clinical evaluation) Imaging tests for DVT and PE Diagnostic combinations Difficult diagnostic situations

4 Goal of Diagnostic Testing for DVT & PE Who needs treatment have VTE & Anticoagulants will do more good than harm Who doesn t need treatment don t have VTE OR VTE but anticoags more harm than good (will resolve and won t recur without Rx) Need to narrow differential diagnosis

5 Ruling-in and Ruling-out a Diagnosis What level of certainty is acceptable?

6 Ruling-in and Ruling-out a Diagnosis What level of certainty is acceptable? Ruling-in (to treat) Depends on toxicity of treatment - high certainty if toxic Ruling-out (not to treat) Depends on consequences of missed diagnosis - high certainty if:(i) rapidly fatal and (ii) effective treatment

7 Ruling-in DVT or PE Probability of PE ³85% Anticoagulants are toxic (~4% bleeding 3 m) Ruling-out DVT or PE Probability recurrent VTE 2% Recurrent PE may be fatal Anticoagulants are very effective (~ 80% RR)

8 100% 85% VTE Diagnosed 50% 2% 0% VTE Excluded management

9 100% 85% PTP prevalence VTE Diagnosed 50% ~25% 2% 0% VTE Excluded management

10 First diagnostic assessment

11 Clinical Assessment of DVT & PE Signs and symptoms Risk factor for VTE Alternative diagnosis as likely

12 Alternative diagnosis as likely -2 Active cancer 1 Paralysis, paresis or plaster cast 1 Bedridden > 3 days (1 month) 1 Tenderness of deep veins 1 Entire leg swollen 1 Calf swelling (3 cm > other leg) 1 Pitting edema 1 Dilated superficial veins 1 History of VTE 1 Total points Clinical Assessment: Low: < 1; Moderate: 1-2; High > 2 for first or recurrent DVT Wells, J Intern Med 1998 Geersing BMJ 2014

13 No other more likely diagnosis 3 Signs & Symptoms of DVT (tender/swelling) 3 Active cancer 1 Previous DVT or PE 1.5 Immobilization / Surgery <4 weeks 1.5 Heart rate > 100/min 1.5 Hemoptysis 1 Total points Clinical Assessment: Low or Unlikely: < 4.5 for PE Wells, Thromb Haemost 2000 Moderate: 4.5-6; High: > 6

14 Wells Model for DVT & PE Clinical Suspicion Prevalence VTE High Moderate Low (15% of patients) (35% of patients) (50% of patients) 75% 25% <10%

15 Wells Model for DVT & PE Clinical Suspicion High Moderate Low Prevalence VTE 75% 25% <10% Likelihood Ratio ~8 ~1 ~0.3

16 100% 85% PTP Clinical PTP VTE Diagnosed High 50% Moderate Low 2% 0% VTE Excluded management

17 D-dimer

18 Cross-linked fibrin Plasmin D-dimer

19 Almost always increased with acute VTE (sensitive test) Increased by other conditions and age (non-specific test)

20 D-dimer Very sensitive: very high NPV, rarely negative ( 95%) ( 98%) (~30%) e.g. D-dimer <500 ug FEU/L Mod sensitive: lower NPV, often negative (~90%) (~95%) (~60%) e.g. SimpliRED +ive or ive

21 100% 85% 50% ~25% PTP prevalence Very Sensitive D-dimer Positive VTE Diagnosed High C-PTP rarely negative lower NPV not worth doing 2% 0% Negative VTE Excluded management

22 100% 85% PTP prevalence Moderately Sensitive D-dimer Mod Sen D-dimer + PTP 50% ~25% 2% 0% Negative Negative + Low PTP

23 To get more negative D-dimers

24 To get more negative D-dimers Increase D-dimer threshold (higher specificity & lower sensitivity) Two ways proposed

25 Age-adjusted D-dimer threshold Theory: Because D-dimer increases with age, can use higher threshold in elderly 50 years Threshold 500ug/L >50 years Threshold = age x 10 ug/l e.g. 78 years x 10 = 780ug/L

26 Age-adjusted D-dimer threshold Supported by: Many retrospective analyses for DVT and PE One prospective cohort of suspected PE Non-high C-PTP & D-dimer 500 to Age x 10 Prevalence: 337/3346 (10.1%) VTE at 3 mo: 1/331 (0.3%, 95%CI ) Righini for ADJUST-PE JAMA 2014

27 C-PTP-adjusted D-dimer threshold Theory: Because less VTE with low C-PTP, can exclude VTE with much higher D-dimer Low C-PTP Threshold 1,000ug/L Moderate C-PTP Threshold 500ug/L 2-fold difference

28 C-PTP-adjusted D-dimer threshold Supported by: Some retrospective analyses for DVT and PE One randomized trial in suspected DVT Low C-PTP CPTP & D-dimer 500 to 999 Prevalence in outpatients: 169/1422 (11.9%) VTE at 3 mo: 0/169 (0%, 95%CI ) RCT comparison: -0.3% (95%CI -1.8 to 0.8) Linkins for SELECT Ann Intern Med 2013

29 D-dimer not worth doing if: Very unlikely to get a negative result very high C-PTP another reason for a positive test Low NPV will not change management very high C-PTP Eg: After surgery; cancer; sepsis

30 Okay! When you can t rule out DVT or PE with Clinical PTP & D-dimer?

31 Diagnostic Imaging for DVT

32 Compression Ultrasonography (CUS) Imaging Test of Choice for DVT

33 US probe US probe No compression Compression

34 Common Femoral Proximal US Whole leg US Calf v. Trifurcation

35 Proximal US Common Femoral Calf v. Trifurcation easy accurate DVT important often diagnostic with C-PTP or D-d alone, does not exclude all DVT may require 2 nd US after 1 week

36 Whole leg US Common Femoral Calf v. Trifurcation (with distal veins) more complex less accurate DVT of uncertain importance excludes all DVT Distal US may be an unhelpful additional test

37 Diagnostic for First DVT US of proximal veins Venography (ascending, CT, MRI) Excludes DVT (including recurrent) Two of: Low C-PTP Negative D-dimer (moderate sensitivity) Negative proximal CUS (or no new vs. pervious) Negative proximal CUS on Day 1 and 7 (serial US) Negative ultrasound of all deep veins Negative D-dimer (very sensitive + non-high C-PTP) Venography of all deep veins

38 Recurrent DVT: additional criteria (thrombus can persist indefinitely) Diagnostic for Recurrent DVT New DVT on proximal US compared to previous (new CFV, Pop, Tri; 4 mm diam; 10 cm longer) Venography (ascending, CT, direct thrombus imaging MRI) Excludes recurrent DVT No new DVT on serial testing (Day 7, Day 14) No acute findings on venography (ascend, CT, MRI)

39 Diagnostic Imaging for PE

40 CT Pulmonary Angiography (CTPA)

41 No PE on CTPA ( & good quality study [~95%]) Multidetector CT, 12 studies; 2982 patients VTE 3 mo follow-up: 1.1% (95% CI ) Carrier J Thromb Haemost 2010

42 Positive Predictive Value of CT by Anatomical Level & Clinical Assessment Clinical Suspicion High Intermed. Low All Main / lobar 96% 99% 89% 97% Segmental 100% 79% 64% 68% Sub-seg. none ~33% ~20% 25%

43 Positive Predictive Value of CT by Anatomical Level & Clinical Assessment Clinical Suspicion High Intermed. Low All Main / lobar 96% 99% 89% 97% Segmental 100% 79% 64% 68% Sub-seg. none ~33% ~20% 25%

44 Ventilation-Perfusion Scanning

45 Ventilation-Perfusion Scanning Often preferred to CTPA Renal impairment Contrast dye allergy Younger (esp. females <40 yr) Pregnancy

46 Ventilation/Perfusion Scan and Clinical Assessment Normal perfusion ~25% Hi-prob & mod/high PTP ~10% Other combinations ~65% (overall prevalence of PE ~20%) PE - + +

47 SPECT V/Q scanning (single-photon emission CT) 3 D ventilation and perfusion imaging better resolution of defects than 2D planar non-diagnostic reduced from ~60% to 5% the general impression is that SPECT is better than planar Stein J Nucl Med 2009; SNM practice Guidelines J Nucl Med 2012

48 SPECT V/Q scanning BUT, NO: Large, prospective, multicentre studies WITH Blind comparison with a criterion standard OR Follow-up after withholding anticoagulation with No PE interpretation

49 Non-diagnostic combinations DVT Hx VTE, abnormal US, D-dimer +ive (Serial US; may treat) Small abnormality on US, D-dimer +ive (Serial US; may treat) PE Non-diagnostic CTPA (technical, small ILFD, Hx VTE) & no DVT & D-dimer +ive (Serial US; 2 nd CTPA) SPECT non-diagnostic V/Q (no CTPA; renal failure) & no DVT & D-dimer +ive (Serial US;?CTPA)

50 Conclusions There is no right way to diagnose DVT & PE (many effective strategies) C-PTP and D-dimer can often exclude DVT/PE Can t always reach a definitive diagnosis Can manage safely when can t reach a definitive diagnosis (often serial tests for DVT)

Diagnostic Algorithms in VTE

Diagnostic Algorithms in VTE Diagnostic Algorithms in VTE Mark H. Meissner, MD Department of Surgery University of Washington School of Medicine Overutilization of Venous Duplex U/S 1983-1993 (Zweibel et al, Australasian Rad, 1995)

More information

Clinical Guide - Suspected PE (Reviewed 2006)

Clinical Guide - Suspected PE (Reviewed 2006) Clinical Guide - Suspected (Reviewed 2006) Principal Developer: B. Geerts Secondary Developers: C. Demers, C. Kearon Background Investigation of patients with suspected pulmonary emboli () remains problematic

More information

Diagnosis of Venous Thromboembolism

Diagnosis of Venous Thromboembolism Diagnosis of Venous Thromboembolism An Educational Slide Set American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism Slide set authors: Eric Tseng MD MScCH, University of

More information

DVT Diagnosis. Reference methods. Whole leg Ultrasonography. Predictive values. Page 1. Diagnosis of 1 st time symptomatic DVT.

DVT Diagnosis. Reference methods. Whole leg Ultrasonography. Predictive values. Page 1. Diagnosis of 1 st time symptomatic DVT. DVT Diagnosis Ulf Nyman Associate Professor Lund University Department of Radiology East Division (Kristianstad, HässleholmH Trelleborg, Ystad) Sweden Diagnosis of 1 st time symptomatic DVT Scientific

More information

New Guidance in AT10 Clive Kearon, MD, PhD,

New Guidance in AT10 Clive Kearon, MD, PhD, New Guidance in AT10 Clive Kearon, MD, PhD, Professor, Department of Medicine, McMaster University; Program Director, McMaster Clinical Investigator Program, McMaster University Head, Clinical Thromboembolism

More information

Proper Diagnosis of Venous Thromboembolism (VTE)

Proper Diagnosis of Venous Thromboembolism (VTE) Proper Diagnosis of Venous Thromboembolism (VTE) Whal Lee, M.D. Seoul National University Hospital Department of Radiology 2 nd EFORT Asia Symposium, 3 rd November 2010, Taipei DVT - Risk Factors Previous

More information

From the Departments of Medicine, University of Ottawa, Ottawa, Canada, McMaster University, Hamilton, Canada, Dalhousie University, Halifax, Canada

From the Departments of Medicine, University of Ottawa, Ottawa, Canada, McMaster University, Hamilton, Canada, Dalhousie University, Halifax, Canada 2000 Schattauer Verlag, Stuttgart Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer Philip S. Wells,

More information

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT OBJECTIVE: To provide guidance on the recommended duration of anticoagulant therapy for venous thromboembolism (VTE). BACKGROUND: Recurrent episodes of VTE

More information

Approach to Thrombosis

Approach to Thrombosis Approach to Thrombosis Theera Ruchutrakool, M.D. Division of Hematology Department of Medicine Siriraj Hospital Faculty of Medicine Mahidol University Approach to Thrombosis Thrombosis: thrombus formation

More information

Epidermiology Early pulmonary embolism

Epidermiology Early pulmonary embolism Epidermiology Early pulmonary embolism Sitang Nirattisaikul Faculty of Medicine, Prince of Songkla University 3 rd most common cause of cardiovascular death in the United States, following ischemic heart

More information

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired

More information

CHAPTER 2 VENOUS THROMBOEMBOLISM

CHAPTER 2 VENOUS THROMBOEMBOLISM CHAPTER 2 VENOUS THROMBOEMBOLISM Objectives Venous Thromboembolism (VTE) Prevalence Patho-physiology Risk Factors Diagnosis Pulmonary Embolism (PE) Management of DVT/PE Prevention VTE Patho-physiology

More information

Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines CHEST Supplement ANTITHROMBOTIC THERAPY AND PREVENTION OF THROMBOSIS, 9TH ED: ACCP GUIDELINES Diagnosis of Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians

More information

The latest on the diagnosis and treatment of venous thromboembolism

The latest on the diagnosis and treatment of venous thromboembolism The latest on the diagnosis and treatment of venous thromboembolism Vicky Tagalakis MD FRCP Division of General Internal Medicine Jewish General Hospital McGill University Disclosures Advisory board Pfizer

More information

Diagnosis and Treatment of Pulmonary Embolism: High-Tech versus Low- Tech, which way to go?

Diagnosis and Treatment of Pulmonary Embolism: High-Tech versus Low- Tech, which way to go? Diagnosis and Treatment of Pulmonary Embolism: High-Tech versus Low- Tech, which way to go? Philip S. Wells MD, FRCPC, MSc Professor Chair and Chief, Department of Medicine, University of Ottawa DISCLOSURE

More information

PULMONARY EMBOLISM/VTE CARE PROCESS MODEL

PULMONARY EMBOLISM/VTE CARE PROCESS MODEL PULMONARY EMBOLISM/VTE CARE PROCESS MODEL IMCP FALL CONFERENCE 2017 Scott Stevens, MD Co-Director, Thrombosis Clinic & Thrombosis Research Group Intermountain Medical Center Professor of Clinical Medicine

More information

Il D-dimero: vantaggi e limiti

Il D-dimero: vantaggi e limiti XXVI Congresso Nazionale FCSA Bologna 5-7 Novembre 2015 Il D-dimero: vantaggi e limiti Gualtiero Palareti Cardiovascular diseases University of Bologna, Italy Degradation of stabilized fibrin DD= Methodolgical

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle  holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/21764 holds various files of this Leiden University dissertation. Author: Mos, Inge Christina Maria Title: A more granular view on pulmonary embolism Issue

More information

ED Diagnosis of DVT or tools to rule out DVT in your ED

ED Diagnosis of DVT or tools to rule out DVT in your ED ED Diagnosis of DVT or tools to rule out DVT in your ED Ralph Wang UCSF Department of Emergency Medicine 53 yo f c/o left leg swelling recent cholecystectomy its midnight how do you manage this patient?

More information

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer

More information

Diagnosis and management of pulmonary embolism

Diagnosis and management of pulmonary embolism Follow the link from the online version of this article to obtain certified continuing medical education credits bmj.com Respiratory Medicine updates from BMJ Group are at bmj.com/specialties/respiratory-medicine

More information

Keynote lecture: Oral anticoagulation and DVT

Keynote lecture: Oral anticoagulation and DVT Keynote lecture: Oral anticoagulation and DVT What is the evidence? Is there a need to anticoagulate every lower leg DVT? Disclosure Speaker name:...sebastian Schellong... I have the following potential

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle   holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/40114 holds various files of this Leiden University dissertation Author: Exter, Paul L. den Title: Diagnosis, management and prognosis of symptomatic and

More information

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT OBJECTIVE: To provide a diagnostic algorithm and treatment options for patients with acute pulmonary embolism (PE). BACKGROUND: Venous thromboembolism (VTE)

More information

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical Pulmonary embolus - a practical approach to investigation and treatment Sam Janes Wellcome Senior Fellow and Respiratory Physician, University College London Background Diagnosis Treatment Common: 50 cases

More information

ACR Appropriateness Criteria Suspected Lower Extremity Deep Vein Thrombosis EVIDENCE TABLE

ACR Appropriateness Criteria Suspected Lower Extremity Deep Vein Thrombosis EVIDENCE TABLE . Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 003; 5():-5.. Hamper UM, DeJong MR, Scoutt LM. Ultrasound

More information

Understanding thrombosis in venous thromboembolism. João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal

Understanding thrombosis in venous thromboembolism. João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal Understanding thrombosis in venous thromboembolism João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal Disclosures João Morais On the last year JM received honoraria

More information

Provider Led Entity. CDI Quality Institute PLE Chest / Pulmonary Embolus AUC 07/31/2018

Provider Led Entity. CDI Quality Institute PLE Chest / Pulmonary Embolus AUC 07/31/2018 Provider Led Entity CDI Quality Institute PLE Chest / Pulmonary Embolus AUC 07/31/2018 Appropriateness of advanced imaging procedures* in patients with suspected or known pulmonary embolus and the following

More information

Individualized prediction in pulmonary embolism; novel concepts and future ideas. Geert-Jan Geersing, MD PhD Family Medicine specialist

Individualized prediction in pulmonary embolism; novel concepts and future ideas. Geert-Jan Geersing, MD PhD Family Medicine specialist Individualized prediction in pulmonary embolism; novel concepts and future ideas. Geert-Jan Geersing, MD PhD Family Medicine specialist Our thrombosis research Since then: 50+ papers Guidelines primary

More information

Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust

Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust MANAGEMENT OF PATIENTS WITH DEEP VEIN THROMBOSIS (DVT) IN THE COMMUNITY SETTING & ANTICOAGULATION CLINICS THE PAST, PRESENT AND THE FUTURE Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital

More information

Pulmonary Thromboembolism

Pulmonary Thromboembolism Pulmonary Thromboembolism James Allen, MD Epidemiology of Pulmonary Embolism 1,500,000 new cases per year in the United States Often asymptomatic 300,000 deaths per year DVT or PE present in 10% of ICU

More information

D-dimer Value more than 3.6 μg/ml is Highly Possible Existence Deep Vein Thrombosis

D-dimer Value more than 3.6 μg/ml is Highly Possible Existence Deep Vein Thrombosis Original Contribution This is Advance Publication Article Kurume Medical Journal, 60, 00-00, 2013 D-dimer Value more than 3.6 μg/ml is Highly Possible Existence Deep Vein Thrombosis SHINICHI NATA, SHINICHI

More information

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism

More information

8,9,10. Deep venous thrombosis (DVT) is clotting of blood in a deep vein of Pulmonary embolism

8,9,10. Deep venous thrombosis (DVT) is clotting of blood in a deep vein of Pulmonary embolism CANCER ASSOCIATED THROMBOSIS DIAGNOSIS OF VTE In patients with cancer-associated thrombosis, landmark studies have demonstrated that effective prophylaxis and treatment of thrombosis reduces morbidity

More information

Mutidisciplinary cooperation on VTE prevention and managment

Mutidisciplinary cooperation on VTE prevention and managment Mutidisciplinary cooperation on VTE prevention and managment TAO YANG Dpartment of vascular surgery Shanxi DAYI Hospita Tai yuan Shanxi China Disclosure Speaker name: Tao Yang... I have the following potential

More information

Thromboembolism and cancer: New practices. Marc Carrier

Thromboembolism and cancer: New practices. Marc Carrier Thromboembolism and cancer: New practices Marc Carrier Marc Carrier Research Support/P.I. Employee Consultant Major Stockholder Speakers Bureau Honoraria Scientific Advisory Board Leo Pharma, BMS No relevant

More information

Anticoagulation Forum: Management of Tiny Clots

Anticoagulation Forum: Management of Tiny Clots Anticoagulation Forum: Management of Tiny Clots Casey O Connell, MD FACP Associate Professor Jane Anne Nohl Division of Hematology Keck School of Medicine USC DISCLOSURES None 4/11/2017 Objectives Define

More information

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144 Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144 Appendix A: Summary of new evidence from Summary of evidence from previous year Diagnosis Diagnostic

More information

Pulmonary embolism: assessment and imaging

Pulmonary embolism: assessment and imaging clinical Sarah Skinner Pulmonary embolism: assessment and imaging Keywords pulmonary embolism; radionuclide imaging; pulmonary embolism/radiography It is estimated that there are approximately 17 000 new

More information

DOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS

DOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS TOKUDA HOSPITAL SOFIA DOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS MILENA STANEVA, MD, PhD Department of vascular surgery and angiology Venous thromboembolic disease continues to cause significant morbidity

More information

Jeffrey Tabas, MD. sf g h. Risk Assessment Do we understand risk stratification? Are we limiting radiation /contrast with the PERC rule and D-Dimers?

Jeffrey Tabas, MD. sf g h. Risk Assessment Do we understand risk stratification? Are we limiting radiation /contrast with the PERC rule and D-Dimers? Pulmonary Embolism Update Jeffrey Tabas, MD Professor UCSF School of Medicine Emergency Department San Francisco General Hospital Disclosure No Financial Relationships to Disclose No significant investments

More information

Scanning the Literature

Scanning the Literature Scanning the Literature Joseph Breault, MD, MPHTM Joseph Guarisco, MD Spiral CTs Are Cost-Effective Paterson DI, Schwartzman K. Strategies incorporating spiral CT for the diagnosis of acute pulmonary embolism:

More information

Radiation Exposure in Pregnancy. John R. Mayo UNIVERSITY OF BRITISH COLUMBIA

Radiation Exposure in Pregnancy. John R. Mayo UNIVERSITY OF BRITISH COLUMBIA Radiation Exposure in Pregnancy John R. Mayo UNIVERSITY OF BRITISH COLUMBIA Illustrative Clinical Scenario 32 year old female 34 weeks pregnant with recent onset shortness of breath and central chest pain

More information

Ultrasonography and Diagnosis of Venous Thromboembolism

Ultrasonography and Diagnosis of Venous Thromboembolism Ultrasonography and Diagnosis of Venous Thromboembolism Brenda K. Zierler, PhD Abstract Venous thromboembolism (VTE) consists of two related conditions: pulmonary embolism (PE) and deep vein thrombosis

More information

BACKGROUND METHODS RESULTS CONCLUSIONS

BACKGROUND METHODS RESULTS CONCLUSIONS CHAPTER 5 The combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis R.E.G. Schutgens 1, P. Ackermark 2, F.J.L.M.

More information

Updates in Diagnosis & Management of VTE

Updates in Diagnosis & Management of VTE Updates in Diagnosis & Management of VTE Financial Disclosures-NONE TRACY MINICHIELLO, MD CHIEF, ANTICOAGULATION& THROMBOSIS SERVICE- SAN FRANCISCO VAMC PROFESSOR OF MEDICINE UNIVERSITY OF CALIFORNIA,

More information

Age-adjusted vs conventional D-dimer thresholds in the diagnosis of venous thromboembolism

Age-adjusted vs conventional D-dimer thresholds in the diagnosis of venous thromboembolism James Madison University JMU Scholarly Commons Physician Assistant Capstones The Graduate School 5-16-2017 Age-adjusted vs conventional D-dimer thresholds in the diagnosis of venous thromboembolism Kirsten

More information

Venous Thromboembolic Disease Update

Venous Thromboembolic Disease Update Canadian Society of Internal Medicine Annual Meeting Calgary, Alberta, October 2014 Venous Thromboembolic Disease Update Benjamin Bell, MD FRCPC James Douketis, MD FRCPC On Behalf of Thrombosis Canada

More information

Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach

Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach Implications from the ACCP 2012 Consensus Guidelines for the Management of Thrombosis: a case based approach Prof. I. Baumgartner Head Clinical and Interventional Angiology About the ACCP guidelines Widely

More information

Too much medicine and venous thromboembolism: How can we make things Well again?

Too much medicine and venous thromboembolism: How can we make things Well again? Too much medicine and venous thromboembolism: How can we make things Well again? Emily G McDonald MD MSc; Assistant professor of medicine; McGill University Health Centre Canadian Society of Internal Medicine;

More information

Patients with suspected DVT of the lower limb how to exam the patient

Patients with suspected DVT of the lower limb how to exam the patient Patients with suspected DVT of the lower limb how to exam the patient Johannes Godt Dep. of Radiology and Nuclear Medicine Oslo University Hospital Ullevål NORDTER 2015, Oslo Content Anatomy and pathophysiology

More information

DVT and Pulmonary Embolus. Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre

DVT and Pulmonary Embolus. Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre DVT and Pulmonary Embolus Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre Overview Structure of deep and superficial venous system of upper

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/188/20915 holds various files of this Leiden University dissertation. Author: Flinterman, Linda Elisabeth Title: Risk factors for a first and recurrent venous

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/19768 holds various files of this Leiden University dissertation. Author: Langevelde, Kirsten van Title: Are pulmonary embolism and deep-vein thrombosis

More information

What s New in DVT & PE

What s New in DVT & PE What s New in DVT & PE Mark Buch MD CM CCFP(EM) Attending physician Emergency Department Jewish General Hospital Family Physician and Medical Director GMF Santé Mont-Royal Objectives: Review the diagnostic

More information

Trombosi venose superficiali e trombosi venose distali

Trombosi venose superficiali e trombosi venose distali XXIV Congresso Nazionale SISET Abano 9-12 Novembre 2016 Trombosi venose superficiali e trombosi venose distali Gualtiero Palareti / Benilde Cosmi Università di Bologna Superficial vein thrombosis (SVT):

More information

Discussion Leader: Doug Bias, M.D.

Discussion Leader: Doug Bias, M.D. In low-risk patients with isolated calf DVT (IDDVT), what is the morbidity risk of treating with repeat ultrasound/observation versus anticoagulation? Discussion Leader: Doug Bias, M.D. Clinical Scenario:

More information

Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital

Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital A few definitions Safe Avoid death, recurrent thrombosis, bleeding Manage Diagnosis + treatment Pulmonary embolism

More information

How to Diagnose Pulmonary Embolism anno 2014?

How to Diagnose Pulmonary Embolism anno 2014? How to Diagnose Pulmonary Embolism anno 2014? Mark H.H. Kramer, MD, PhD, FRCP FACP Professor of Medicine VU University Medical Center Amsterdam, The Netherlands What are we going to discuss? Age adjusted

More information

Oral rivaroxaban versus standard therapy for the acute and continued treatment of symptomatic deep vein thrombosis. The EINSTEIN DVT study.

Oral rivaroxaban versus standard therapy for the acute and continued treatment of symptomatic deep vein thrombosis. The EINSTEIN DVT study. Oral rivaroxaban versus standard therapy for the acute and continued treatment of symptomatic deep vein thrombosis. The EINSTEIN DVT study Comments Harald Darius, Berlin Disclosures for Harald Darius Research

More information

Expanding the treatment options of Superficial vein thrombosis with Rivaroxaban

Expanding the treatment options of Superficial vein thrombosis with Rivaroxaban Expanding the treatment options of Superficial vein thrombosis with Rivaroxaban Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, School of Health

More information

Clinical Reasoning: Use of Diagnostic Testing

Clinical Reasoning: Use of Diagnostic Testing Clinical Reasoning: Use of Diagnostic Testing Viju John, MD OCTOBER 21, 2016 Objectives 1. Determine pre and post-test probability. 2. Understand the concepts of threshold to test and a threshold to treat.

More information

Duration of Therapy for Venous Thromboembolism

Duration of Therapy for Venous Thromboembolism Duration of Therapy for Venous Thromboembolism Michael B Streiff, MD FACP Associate Professor of Medicine and Pathology Medical Director, Johns Hopkins Anticoagulation Service Chairman, VTE Guideline Committee

More information

Duration of anticoagulation

Duration of anticoagulation Duration of anticoagulation P. Fontana Service d angiologie et d hémostase Hôpitaux Universitaires de Genève Pomeriggio formativo in coagulazione, Bellinzona, 19.10.2017 Conflict of interest AstraZeneca,

More information

Mabel Labrada, MD Miami VA Medical Center

Mabel Labrada, MD Miami VA Medical Center Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and

More information

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur

More information

DEEP VEIN THROMBOSIS (DVT): TREATMENT

DEEP VEIN THROMBOSIS (DVT): TREATMENT DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada

More information

ORIGINAL INVESTIGATION

ORIGINAL INVESTIGATION Use of a Clinical Decision Rule in Combination With D-Dimer Concentration in Diagnostic Workup of Patients With Suspected Pulmonary Embolism A Prospective Management Study ORIGINAL INVESTIGATION Marieke

More information

Underuse of risk assessment and overuse of CTPA in patients with suspected pulmonary thromboembolism

Underuse of risk assessment and overuse of CTPA in patients with suspected pulmonary thromboembolism Underuse of risk assessment and overuse of CTPA in patients with suspected pulmonary thromboembolism Michael Perera Advanced Trainee in General and Acute Medicine Leena Aggarwal Director, Medical Assessment

More information

What is the impact of Superficial Vein Thrombosis?

What is the impact of Superficial Vein Thrombosis? What is the impact of Superficial Vein Thrombosis? Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, University of Thessalia, Greece Chairman,

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle   holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/40114 holds various files of this Leiden University dissertation Author: Exter, Paul L. den Title: Diagnosis, management and prognosis of symptomatic and

More information

Pulmonary embolism? A rapid disposition can be a matter of life or death.

Pulmonary embolism? A rapid disposition can be a matter of life or death. Pulmonary embolism? A rapid disposition can be a matter of life or death. Not all D-dimer tests are created equal. D-dimer assays are known to have varying sensitivities. 8,9,10 ELISA and FIA assays have

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Mismetti P, Laporte S, Pellerin O, Ennezat P-V, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone

More information

Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC

Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC 1 st workshop: update to VTE guidelines in 2016 2 nd workshop: VTE controversies + new horizons André Roussin MD, FRCP, CSPQ CHUM

More information

Pulmonary embolism: Acute management. Cecilia Becattini University of Perugia, Italy

Pulmonary embolism: Acute management. Cecilia Becattini University of Perugia, Italy Pulmonary embolism: Acute management Cecilia Becattini University of Perugia, Italy Acute pulmonary embolism: Acute management Diagnosis Risk stratification Treatment Non-high risk PE: diagnosis 3-mo VTE

More information

Differences in clinical presentation of pulmonary embolism in women and men

Differences in clinical presentation of pulmonary embolism in women and men Journal of Thrombosis and Haemostasis, 8: 693 698 DOI: 10.1111/j.1538-7836.2010.03774.x ORIGINAL ARTICLE Differences in clinical presentation of pulmonary embolism in women and men H. ROBERT-EBADI,* G.

More information

Controversies in Venous Thromboembolism

Controversies in Venous Thromboembolism Controversies in Venous Thromboembolism Menaka Pai, BSc MSc MD FRCPC Assistant Professor, Department of Medicine, McMaster University Associate Member, Department of Pathology and Molecular Medicine, McMaster

More information

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness

More information

Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range

Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range Suspect a DVT? Complete a Two-level DVT Wells score on ICE system (see page

More information

Author(s): Rockefeller A. Oteng, M.D., University of Michigan

Author(s): Rockefeller A. Oteng, M.D., University of Michigan Project: Ghana Emergency Medicine Collaborative Document Title: Pulmonary Embolism Part 2 (2012) Author(s): Rockefeller A. Oteng, M.D., University of Michigan License: Unless otherwise noted, this material

More information

suspected deep-vein thrombosis is a common condition, with a lifetime cumulative incidence of 2 to 5 percent. Untreated deep-vein thrombosis can resul

suspected deep-vein thrombosis is a common condition, with a lifetime cumulative incidence of 2 to 5 percent. Untreated deep-vein thrombosis can resul original article Evaluation of d-dimer in the Diagnosis of Suspected Deep-Vein Thrombosis Philip S. Wells, M.D., David R. Anderson, M.D., Marc Rodger, M.D., Melissa Forgie, M.D., Clive Kearon, M.D., Ph.D.,

More information

Assessment of the safety using age adjusted D-dimer to rule out venous thromboembolism in a Swedish Emergency Department

Assessment of the safety using age adjusted D-dimer to rule out venous thromboembolism in a Swedish Emergency Department Assessment of the safety using age adjusted D-dimer to rule out venous thromboembolism in a Swedish Emergency Department Herman Tagger 1, Helene Kildegaard Jensen 2, Annmarie Touborg Lassen 2, Ulf Ekelund

More information

Duration of Anticoagulant Therapy. Linda R. Kelly PharmD, PhC, CACP September 17, 2016

Duration of Anticoagulant Therapy. Linda R. Kelly PharmD, PhC, CACP September 17, 2016 Duration of Anticoagulant Therapy Linda R. Kelly PharmD, PhC, CACP September 17, 2016 Conflicts of Interest No conflicts of interest to report Objectives At the end of the program participants will be

More information

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 16 December 1999 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON CLINICAL

More information

New areas of development for the direct oral anticoagulants

New areas of development for the direct oral anticoagulants New areas of development for the direct oral anticoagulants Varese March 2016 Disclosures for Harry R Büller Research Support/P.I. Employee Consultant Major Stockholder Speakers Bureau Scientific Advisory

More information

Citation for published version (APA): Douma, R. A. (2010). Pulmonary embolism: advances in diagnosis and prognosis

Citation for published version (APA): Douma, R. A. (2010). Pulmonary embolism: advances in diagnosis and prognosis UvA-DARE (Digital Academic Repository) Pulmonary embolism: advances in diagnosis and prognosis Douma, R.A. Link to publication Citation for published version (APA): Douma, R. A. (2010). Pulmonary embolism:

More information

Acute Pulmonary Embolism and Deep Vein Thrombosis. Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center COPYRIGHT

Acute Pulmonary Embolism and Deep Vein Thrombosis. Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center COPYRIGHT Acute Pulmonary Embolism and Deep Vein Thrombosis Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center Acute PE and DVT No disclosures. Acute PE and DVT Learning objectives

More information

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality

More information

Risk-Based Evaluation and Management of VTE

Risk-Based Evaluation and Management of VTE 12:50-1:50pm Risk-Based Evaluation and Management of VTE SPEAKER Gregory Piazza, MD, MS BRIGHAM AND WOMEN S HOSPITAL Risk-Based Evaluation and Management of VTE Gregory Piazza, MD, MS Assistant Professor

More information

Canadian Society of Internal Medicine Annual Meeting 2017 Toronto, ON

Canadian Society of Internal Medicine Annual Meeting 2017 Toronto, ON Canadian Society of Internal Medicine Annual Meeting 2017 Toronto, ON How to Prevent and Manage the Post-Thrombotic Syndrome? Jean-Philippe Galanaud Clinical Thromboembolism & Division of GIM Sunnybrook,

More information

Clinical Cases with Deep Venous Thrombosis - The position of Apixaban Stavros KAKKOS, MD, MSc, PhD, RVT

Clinical Cases with Deep Venous Thrombosis - The position of Apixaban Stavros KAKKOS, MD, MSc, PhD, RVT Clinical Cases with Deep Venous Thrombosis - The position of Apixaban Stavros KAKKOS, MD, MSc, PhD, RVT Department of Vascular Surgery. University Hospital of Patras Chairman: Ioannis Tsolakis DISCLAIMER

More information

Indications of Anticoagulants; Which Agent to Use for Your Patient? Marc Carrier MD MSc FRCPC Thrombosis Program Ottawa Hospital Research Institute

Indications of Anticoagulants; Which Agent to Use for Your Patient? Marc Carrier MD MSc FRCPC Thrombosis Program Ottawa Hospital Research Institute Indications of Anticoagulants; Which Agent to Use for Your Patient? Marc Carrier MD MSc FRCPC Thrombosis Program Ottawa Hospital Research Institute Disclosures Research Support/P.I. Employee Leo Pharma

More information

Blood Day for Primary Care

Blood Day for Primary Care Blood Day for Primary Care including the Anticoagulation, use of novel oral anticoagulants in DVT/PE & atrial fibrillation Marc Carrier MD MSc. FRCPC Department of Internal Medicine, Division of Hematology,

More information

Citation for published version (APA): Douma, R. A. (2010). Pulmonary embolism: advances in diagnosis and prognosis

Citation for published version (APA): Douma, R. A. (2010). Pulmonary embolism: advances in diagnosis and prognosis UvA-DARE (Digital Academic Repository) Pulmonary embolism: advances in diagnosis and prognosis Douma, R.A. Link to publication Citation for published version (APA): Douma, R. A. (2010). Pulmonary embolism:

More information

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle  holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/21764 holds various files of this Leiden University dissertation. Author: Mos, Inge Christina Maria Title: A more granular view on pulmonary embolism Issue

More information

Anticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis

Anticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis Anticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis Tim Sebastian, M.D. University Hospital Zurich Clinic for Angiology Disclosure Speaker name: Tim Sebastian I

More information

Pulmonary Embolism. Thoracic radiologist Helena Lauri

Pulmonary Embolism. Thoracic radiologist Helena Lauri Pulmonary Embolism Thoracic radiologist Helena Lauri 8.5.2017 Statistics 1-2 out of 1000 adults annually are diagnosed with deep vein thrombosis (DVT) and/or pulmonary embolism (PE) About half of patients

More information